NewsMarkets

Business

Kobayashi Pharmaceutical in $3.2 Billion Buyout Talks After Scandal

Private equity investors are considering a buyout offer for the Japanese firm amid a supplement contamination scandal.

2 publishers · 2 articles · first seen 24 Sept 2026 · updated 2h ago

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Kobayashi in $3.2 Billion Buyout Talks After Red-Yeast Scandal Bloomberg Markets ·
  2. Kobayashi in ¥500 billion buyout talks after red-yeast case Latest articles

In this story

  • Kobayashi Pharmaceutical Co.